Halozyme Therapeutics
HALO
#1703
Rank
NZ$22.17 B
Marketcap
NZ$195.38
Share price
2.73%
Change (1 day)
58.97%
Change (1 year)

Earnings for Halozyme Therapeutics (HALO)

Earnings in 2026 (TTM): NZ$1.01 Billion

According to Halozyme Therapeutics's latest financial reports the company's current earnings are NZ$1.66 Billion. In 2025 the company made an earning of NZ$0.83 Billion a decrease over its 2024 earnings that were of NZ$0.99 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Halozyme Therapeutics from 2002 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) NZ$1.01 B22.72%
2025 NZ$0.83 B-16.2%
2024 NZ$0.99 B59.94%
2023 NZ$0.61 B39.94%
2022 NZ$0.44 B0.16%
2021 NZ$0.44 B92.2%
2020 NZ$0.22 B-278.96%
2019 -NZ$0.13 Billion-9.45%
2018 -NZ$0.15 Billion-229.51%
2017 NZ$0.10 B-160.48%
2016 -NZ$0.19 Billion216.03%
2015 -NZ$57.32 Million-52.86%
2014 -NZ$0.13 Billion-18.09%
2013 -NZ$0.15 Billion55.88%
2012 -NZ$95.24 Million169.94%
2011 -NZ$35.29 Million-63.44%
2010 -NZ$96.5 Million-7.19%
2009 -NZ$0.11 Billion15.91%
2008 -NZ$89.7 Million83.89%
2007 -NZ$48.78 Million78.1%
2006 -NZ$27.39 Million16%
2005 -NZ$23.61 Million45.24%
2004 -NZ$16.26 Million682.42%
2003 -NZ$2.08 Million1659.12%
2002 -NZ$0.12 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Johnson & Johnson
JNJ
NZ$46.60 B 4,392.76%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
NZ$12.28 B 1,084.05%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
NZ$59.74 B 5,659.20%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
NZ$12.73 B 1,127.47%๐Ÿ‡ซ๐Ÿ‡ท France
Baxter
BAX
-NZ$0.86 Billion-182.80%๐Ÿ‡บ๐Ÿ‡ธ USA
MannKind Corp
MNKD
-NZ$86.53 Million-108.34%๐Ÿ‡บ๐Ÿ‡ธ USA